ArriVent BioPharma (AVBP) Q3 2025 Earnings

11AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.9
-1.47
-1.03
-0.6

Details

Expected EPS
-0.712222
Actual EPS
-0.9
Surprise EPS
-0.19
Surprise Percent
+26.37%

Description

ArriVent BioPharma (AVBP) has reported earnings of -0.9 per share for Q3 2025.

0 Comments

Share your thoughts